Mootrashmari Treatment With Palasha Kshara And Ashmarihara Kwatha

Phase 3

Not yet recruiting

• Conditions: Patient diagnosed with Mootrashmari

• Registration Number: CTRI/2018/01/011199
• Lead Sponsor: Institute for Post Graduate Training And Research Centre

Brief Summary

This study comprises a Clinical Study to evaluate the effect of  Palasha kshara and Ashmarihara kwatha in the management of Mootrashmari w.s.r. Urolithiasis. The pathogenesis of Mootrashmari involve one important factor i.e. Kapha dosha dusti . Kshara having bhedana property and Ashmarihara kwath containing bhedana drug will not only reduce the stone size but also will maintain the Renal function. But as per claim of some of the Urologists that stone size less than 10 mm is excreted out without any kind of medication , so in another group Placebo capsule  and intake of plenty of water is advisable to patient . Thus this will not only validate the effetiveness of Ayurvedic drugs but will also prove its efficacy on Mootrashmari .

Procedure-

In one group, for 60 days Palasha kshara capsule ( 500 mg ) TDS , Ashmarihara kwatha 40 ml TDS and pathya ahara is advised and  in another group Placebo capsule ( 500 mg ) TDS , drinking of  more than 2 litres of water and pathya ahara is advised and result will be noticed after 60 days through X Ray (KUB) and USG ( W/A and pelvis).

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-25
• Last Update Posted: 2018-08-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Patient having age between 18 to 70 years 2) Stone size upto 10 mm 3) Patients of ashmari with controlled HTN and Diabetes Mellitus 4) Renal and Ureteric stone will be included.

Exclusion Criteria

1)Age below 18 years and above 70 years 2)Chronic Renal Failure 3)Gross Hydronephrosis 4)Acute Abdominal Pain 5)Cases which require Surgical Intervention 6)Severe Hematuria 7) Stone size more than 10 mm 8)Stone present in urinary bladder and urethera 9) Known cases of HIV, VDRL, Hepatitis, HTN ,Diabetes Mellitus,Cardiac disorders Malignancy ,TB.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in sign and symptoms of Mootrashmari	60 Days

Secondary Outcome Measures

Name	Time	Method
Improves quality of life of the person	Improves quality of life of the person

Trial Locations

Locations (1)

PG Hospital IPGT and RA GAU Jamnagar Gujarat; 🇮🇳 Jamnagar, GUJARAT, India

PG Hospital IPGT and RA GAU Jamnagar Gujarat

🇮🇳Jamnagar, GUJARAT, India

Monika Kumari

Principal investigator

9506817420

dr.monika19@rediffmail.com